Clinical trial
Pharmacokinetics of the Tablet Formulation of Lopinavir/r as Standard and Increased Dosage During Pregnancy in HIV-infected Women
NCT00605098 is registered in ClinicalTrials.gov with Oswaldo Cruz Foundation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pharmacokinetics of the Tablet Formulation of Lopinavir/r as Standard and Increased Dosage During Pregnancy in HIV-infected Women
- Lead sponsor
- Oswaldo Cruz Foundation
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 29, 2008
- Completion date
- July 31, 2012
- Enrollment
- 60 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
hiv infections, pregnancy